Home
electronic Patient Benefit Index
ePBI
Quick and easy assessment of
therapy benefit
What is the ePBI?
ePBI is an instrument for dermatological patients and their physicians based on the Patient Benefit Index (PBI). The PBI is used in experimental dermatology to evaluate the efficacy and safety of drugs used for the treatment of psoriasis, while patient reported needs and benefits are collected. It can also be gathered for quality assurance and shared decision making. ePBI is available as a mobile application for Android and iOS devices, as well as a web-based online calculator.
Validation of questionnaire
paper version: yes digital version: yes
How to use the ePBI
Before the beginning of treatment, the patient completes a questionnaire on their treatment goals (PNQ: Patient Needs Questionnaire) and indicates how important these are to them on a 5-point scale from "not at all" to " very" or whether they do not apply to them. After starting treatment, the patient completes the Patient Benefit Questionnaire (PBQ) and indicates the extent to which the treatment has helped them to achieve the previously listed goals or whether these did not apply to them. Once again, this is rated on a 5-point scale from "not at all" to "very". Finally, the overall benefit of the therapy is calculated from the answers given.
The index range is between 0 (no patient relevant benefit) and 4 (maximum patient relevant benefit).
Below is an example of the PBI calculation process in four steps.
1) Importance of treatment goals
With the help of the following questions, we’d like to know how important the below mentioned goals are to you personally in the current treatment.
For each of the following statements, please mark how important this treatment goal is to you. If a statement does not apply to you, e.g. because you do not have pain, please mark “does not apply to me“.
2) Treatment benefits
Please fill in the type of treatment for skin disease that you are currently undergoing (or which you underwent last):
Treatment: _____________________________ Since when?: _____________________
O No treatment of skin disease over the last 12 months (→ please continue on the next page!)
Please mark for each of the following statements how well the goals of the current treatment have already been met and how beneficial the treatment has been. If a statement did not apply to you, e.g. because you had no pain, please mark “did not apply to me”.
3) Calculation PBI
4) View of results (example)
Want to know more?
Structure and scope of the Patient Benefit Index
Want to know more?
Structure and scope of the Patient Benefit Index
The following versions of the ePBI are available
Endpoint Model: Treatment of Disease X
Food and Drug Administration. Guidance for industry – Patient-Reported Outcome Measures: Use in medical product development to support labeling claims. US Food and Drug administration website, 2009 [cited 2017]
About Patient Reported Outcomes
“A PRO is any report of the status of a patient’s health condition that comes directly from the patient, without interpretation of the patient’s response by a clinician or anyone else.”
“Use of a PRO instrument is advised when measuring a concept best known by the patient or best measured from the patient perspective. […] PRO instrument adequacy depends on its role and relationships with other clinical trial endpoints as depicted in the endpoint model.”
Features
USER-FRIENDLY
The intuitive and interactive design of the ePBI ensures easy understanding of all questions, whether for physicians or patients.
QUICK
Save time with our online tool. Fill in the questionnaire and your ePBI score will be calculated automatically.
RESULT FEEDBACK
On DermaValue, you not only get your PBI value, but also learn what it means in terms of your therapy benefit.
MULTILINGUAL
The PBI is an established tool and available in several languages. The use of the respective first language reduces language barriers and supports the understanding between physician and patient.
RESPONSIVE AND MULTI-DEVICE
With DermaValue, your ePBI is always just a few clicks away. The application is available for PCs, tablets, smartphones, and other devices.
ENVIRONMENTALLY FRIENDLY
Take care of the environment and save your patient data on the online platform or as PDF files for yourself and your physicians.
References
Validation study:
Feuerhahn J, Blome C, Radtke M, Augustin M. Validation of the patient benefit index for the assessment of patient-relevant benefit in the treatment of psoriasis. Arch Dermatol Res. 2012 Aug;304(6):433-41. doi: 10.1007/s00403-012-1256-y . Epub 2012 Jun 22. PMID: 22722916 .
Our other tools
Our partners
